Home > News > Events 31 July 2013 Novo Nordisk celebrates 90 years for diabetes Danish pharmaceutical company Novo Nordisk has recently celebrated the completion of 90 years since the first diabetes patients were treated with the company's insulin. 0 Novo Nordisk Danish pharmaceutical company Novo Nordisk has recently celebrated the completion of 90 years since the first diabetes patients were treated with the company's insulin. Ever since, the company has been focused on developing new and better treatments for people with diabetes and is today the world's largest diabetes care company. Novo Nordisk provides therapeutic treatments for an estimated 23 million people with diabetes worldwide and produces approximately 50 per cent of all insulin in the world. Dr. Timmy Kedijang, the General Manager of Novo Nordisk South Africa says “expanding waistlines are causing an epidemic of Type 2 diabetes around the world, and lifestyle management is as important as appropriate medical treatment.”The company’s story began in 1921, shortly after a team of scientists in Canada discovered insulin. FoundationDr Marie Krogh - a Danish medical doctor and scientist who had type 2 diabetes herself - was quick to realise the importance of this discovery. Marie and August Krogh set up a foundation called Nordisk Insulinlaboratorium, and made this the company’s majority shareholder in order to secure its independence. The foundation was also used as a channel to provide grants for research and humanitarian purposes. A similar foundation was established in 1951 by Novo’s founders, Harald Petersen and Thorvald Pedersen, and the foundation-based business model has been maintained since the subsequent merger of the two companies. Holistic approachWith the merger of two Danish pioneering foundations (Novo and Nordisk) in 1989, it continues to be at the forefront of developing new insulin delivery systems and advocating for a holistic approach to preventing and managing diabetes."Approximately 371 million people worldwide are living with diabetes," says Dr. Kedijang, "and this could rise to 550 million by 2030. "At Novo Nordisk we therefore see our role not only as a provider of the very best treatment options, but also as a leader in facilitating access to lifestyle education and diabetes testing and treatment. Our founders set the bar very high, and we intend to keep raising it." The first few years and history can be viewed via this video: http://video.novonordisk.com/video/7772789/novo-nordisk-90th-anniversary-defining More in News Fortinet Named Platinum Sponsor for 2016 Healthcare Innovation Summit More: NewsEvents advertisement Read Health24’s Comments Policy Comment on this story 0 comments Comments have been closed for this article. Logout Comment 0 characters remaining Share on Facebook Loading comments... Other news Medical Bacteria may slow the spread of Zika Medical British babies tested for cholesterol Fitness 9 ways yoga can improve your sex life Medical Natural disasters linked to dementia Medical When your bowel movements go wrong . . . News Nerve stimulation restores sense of touch to arm amputees From our sponsors Keep an eye on your vision Which skin products are better, ‘medical grade’ or ‘over-the-counter’? Win 1 of 6 R5000 cash prizes Win a R2 000 Skin Renewal voucher Live healthier Exercise benefits for seniors » Working out in the concrete jungle Even a little exercise may help prevent dementia Here’s an unexpected way to boost your memory: running Seniors who exercise recover more quickly from injury or illness When sedentary older adults got into an exercise routine, it curbed their risk of suffering a disabling injury or illness and helped them recover if anything did happen to them. No relief for MS » Drug shows promise against MS in mouse study Vitamin D may slow multiple sclerosis Obesity in girls tied to higher MS risk Exercise may not lower women's risk of MS A Harvard study showed no evidence to support the idea that exercise lowers the risk of multiple sclerosis.